LJUIF (SSY Group) Common Stock: $8.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LJUIF SSY Group Ltd LJUIF
86 GF Score
Price $0.40
GF Value $0.51
! 8 Warning Signs
View Full Analysis

What is SSY Group Common Stock?

SSY Group LJUIF 86 Common Stock is $8.5 Mil as of Dec. 2025. GuruFocus rates LJUIF with a GF Score™ of 86/100 and a GF Value™ of $0.51. The stock has 8 warning signs investors should review.

SSY Group's quarterly common stock declined from Dec. 2024 ($8.5 Mil) to Jun. 2025 ($8.4 Mil) but then increased from Jun. 2025 ($8.4 Mil) to Dec. 2025 ($8.5 Mil).

SSY Group's annual common stock increased from Dec. 2023 ($8.5 Mil) to Dec. 2024 ($8.5 Mil) but then declined from Dec. 2024 ($8.5 Mil) to Dec. 2025 ($8.5 Mil).

SSY Group Common Stock Historical Data

* Premium members only.

The historical data trend for SSY Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SSY Group Common Stock Chart

SSY Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.56 8.51 8.48 8.49 8.46

SSY Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.48 8.48 8.49 8.39 8.46
LJUIF
86GF Score
SSY Group Ltd LJUIF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SSY Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $8.5 Mil mean?
SSY Group (LJUIF) has a Common Stock of $8.5 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SSY Group and its competitors.
Is SSY Group's Common Stock too high?
SSY Group's current Common Stock is $8.5 Mil. Overall, SSY Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does SSY Group's Common Stock compare to ZTS?
SSY Group's Common Stock of $8.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on SSY Group and its competitors. SSY Group's current Common Stock is $8.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
SSY Group (LJUIF) has a current Common Stock of $8.5 Mil. The stock's GF Value™ is $0.51, compared to a current price of $0.40 — trading 21.1% below its estimated fair value. The current Common Stock is $8.5 Mil. SSY Group's overall GF Score™ is 86/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For SSY Group (LJUIF), the current Common Stock is $8.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SSY Group (LJUIF) Overvalued in 2026?

Based on GuruFocus' analysis, SSY Group stock appears to be undervalued. The current stock price of $0.40 is trading 21.1% below its estimated GF Value™ of $0.51.

Key valuation signals for LJUIF:

  • Common Stock: $8.5 Mil
  • GF Value™: $0.51 vs. price of $0.40 (21.1% below fair value)
  • GF Score™: 86/100 with 8 warning signs

No single metric tells the full story. See the LJUIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SSY Group Business Description

Other Exchanges 02005:Hong Kong
Address Central Plaza, 18 Harbour Road, Rooms 4902-03, 49th Floor, Wanchai, Hong Kong, HKG
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score

Get the complete analysis for LJUIF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.51
GF Value